The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Nanoparticles for Imaging: Top or Flop?
Open accessAbstract
Nanoparticles are frequently suggested as diagnostic agents. However, except for iron oxide nanoparticles, diagnostic nanoparticles have been barely incorporated into clinical use so far. This is predominantly due to difficulties in achieving acceptable pharmacokinetic properties and reproducible particle uniformity as well as to concerns about toxicity, biodegradation, and elimination. Reasonable indications for the clinical utilization of nanoparticles should consider their biologic behavior. For example, many nanoparticles are taken up by macrophages and accumulate in macrophage-rich tissues. Thus, they can be used to provide contrast in liver, spleen, lymph nodes, and inflammatory lesions (eg, atherosclerotic plaques). Furthermore, cells can be efficiently labeled with nanoparticles, enabling the localization of implanted (stem) cells and tissue-engineered grafts as well as in vivo migration studies of cells. The potential of using nanoparticles for molecular imaging is compromised because their pharmacokinetic properties are difficult to control. Ideal targets for nanoparticles are localized on the endothelial luminal surface, whereas targeted nanoparticle delivery to extravascular structures is often limited and difficult to separate from an underlying enhanced permeability and retention (EPR) effect. The majority of clinically used nanoparticle-based drug delivery systems are based on the EPR effect, and, for their more personalized use, imaging markers can be incorporated to monitor biodistribution, target site accumulation, drug release, and treatment efficacy. In conclusion, although nanoparticles are not always the right choice for molecular imaging (because smaller or larger molecules might provide more specific information), there are other diagnostic and theranostic applications for which nanoparticles hold substantial clinical potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like almost all other nanoparticles, intravenously administered SPION are eventually cleared by macrophages in liver, spleen, lymph nodes and bone marrow, the also called mononuclear phagocytic system (MPS) [143].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,775
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Kim, S., Lim, Y. T., Soltesz, E. G., Grand, A. M. D., Lee, J., Nakayama, A., Parker, J. A., Mihaljevic, T., Laurence, R. G., Dor, D. M., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt920 · Cited by 2,087
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,791
Complexity in biomaterials for tissue engineering
Place, E., Evans, N. D., & Stevens, M. M. (2009) · Nature Materials · doi:10.1038/nmat2441 · Cited by 1,769
Nano-graphene in biomedicine: theranostic applications
Yang, K., Feng, L., Shi, X., & Liu, Z. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35342c · Cited by 1,642
Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,504
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,444
Research works printed but not linked: 8
- Matsumura Y, 1986, Cancer Res, 46, 6387
- Settles M, 2011, PLoS ONE, 6
- Kircher MF, 2003, Cancer Res, 63, 6838
- Zhou R, 2005, J Nucl Med, 46, 816
- Grimm J, 2006, Mol Imaging, 5
- Reuveni T, 2011, Int J Nanomedicine, 6, 2859
- Harrington KJ, 2001, Clin Cancer Res, 7, 243
- Kaittanis C, 2014, Published online
Cited by
Sorted by citations
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,279
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,084
Calcium phosphates in biomedical applications: materials for the future?
Habraken, W. J. E. M., Habibović, P., Epple, M., & Bohner, M. (2015) · Materials Today · doi:10.1016/j.mattod.2015.10.008 · Cited by 854
Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy
Haupt, K., Rangel, P. X. M., & Bui, B. T. S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00428 · Cited by 581
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496
Self-citationApplications of nanoparticles for diagnosis and therapy of cancer
Baetke, S. C., Lammers, T., & Kiessling, F. M. (2015) · British Journal of Radiology · doi:10.1259/bjr.20150207 · Cited by 515
Bhatia, S. N., Chen, X. S., Dobrovolskaia, M. A., & Lammers, T. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00496-9 · Cited by 433
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Self-citationUltrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
Zarschler, K., Rocks, L., Licciardello, N., Boselli, L., Polo, E., García, K. P., Cola, L. D., Stephan, H., & Dawson, K. A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.02.019 · Cited by 307
Grasso, G., Zane, D., & Dragone, R. (2019) · Nanomaterials · doi:10.3390/nano10010011 · Cited by 303
Burlec, A. F., Corciovă, A., Boev, M., Batir, D. M., Mircea, C., Cioancă, O., Danila, G., Dănilă, D. M., Bucur, A. F., & Hăncianu, M. (2023) · Pharmaceuticals · doi:10.3390/ph16101410 · Cited by 329
Perspectives on the past, present, and future of cancer nanomedicine
Youn, Y. S., & Bae, Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.008 · Cited by 288
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
Paefgen, V., Doleschel, D., & Kiessling, F. M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00197 · Cited by 273
Recent Development of Inorganic Nanoparticles for Biomedical Imaging
Kim, D., Kim, J., Park, Y. I., Lee, N., & Hyeon, T. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00574 · Cited by 276
Tumor-targeted nanomedicines for cancer theranostics
Arranja, A., Pathak, V., Lammers, T., & Shi, Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.014 · Cited by 249
Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries
Amani, H., Habibey, R., Hajmiresmail, S. J., Latifi, S., Pazoki–Toroudi, H., & Akhavan, O. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01689a · Cited by 220
Chen, F., Hableel, G., Zhao, E. R., & Jokerst, J. V. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.02.053 · Cited by 205
Nanoparticles for bone tissue engineering
Vieira, S., Vial, S., Reis, R. L., & Oliveira, J. M. (2017) · Biotechnology Progress · doi:10.1002/btpr.2469 · Cited by 200
Biomedical Metal–Organic Framework Materials: Perspectives and Challenges
Wang, A., Walden, M., Ettlinger, R. L., Kiessling, F. M., Gassensmith, J. J., Lammers, T., Wuttke, S., & Peña, Q. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202308589 · Cited by 213
Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease
Gupta, J., Fatima, M. T., Islam, Z., Khan, R. H., Uversky, V. N., & Salahuddin, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.156 · Cited by 163
Kim, H.-Y., Li, R., Ng, T. S. C., Courties, G., Rodell, C. B., Prytyskach, M., Köhler, R. H., Pittet, M. J., Nahrendorf, M., Weissleder, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b04338 · Cited by 145
Fusco, L., Gazzi, A., Peng, G., Shin, Y., Vranic, S., Bedognetti, D., Vitale, F., Yılmazer, A., Feng, X., Fadeel, B., et al. (2020) · Theranostics · doi:10.7150/thno.40068 · Cited by 140
Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy
Meng, Q., Rao, L., Zan, M., Chen, M., Yu, G., Wei, X., Wu, Z., Sun, Y., Guo, S., Zhao, X., et al. (2018) · Nanotechnology · doi:10.1088/1361-6528/aaa7c7 · Cited by 138
Application of nanotechnology in medical diagnosis and imaging
Singh, A., & Amiji, M. M. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.12.011 · Cited by 135
Parisi, O. I., Francomano, F., Dattilo, M., Patitucci, F., Prete, S., Amone, F., & Puoci, F. (2022) · Journal of Functional Biomaterials · doi:10.3390/jfb13010012 · Cited by 142
Skotland, T., Iversen, T., Llorente, A., & Sandvig, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114326 · Cited by 134
Burke, B. P., Grantham, W., Burke, M. J., Nichol, G. S., Roberts, D. P., Renard, I., Hargreaves, R., Cawthorne, C., Archibald, S. J., & Lusby, P. J. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09582 · Cited by 119
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Xu, H., Li, S., & Liu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01082-z · Cited by 130
MUC1 Aptamer Targeted SERS Nanoprobes
Pal, S., Harmsen, S., Oseledchyk, A., Hsu, H., & Kircher, M. F. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606632 · Cited by 113
Functionalized heteroatom-doped carbon dots for biomedical applications: A review
Redondo-Fernández, G., Canga, J. C., Soldado, A., Encinar, J. R., & Costa-Fernandez, J. M. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341874 · Cited by 112
Activatable fluorescence: From small molecule to nanoparticle
Luby, B. M., Charron, D. M., MacLaughlin, C. M., & Zheng, G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.010 · Cited by 107
Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 103
An update on nanoparticle-based contrast agents in medical imaging
Naseri, N., Ajorlou, E., Asghari, F., & Pilehvar‐Soltanahmadi, Y. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1379014 · Cited by 100
Physically stimulus-responsive nanoparticles for therapy and diagnosis
Farjadian, F., Ghasemi, S., Akbarian, M., Hoseini‐Ghahfarokhi, M., Moghoofei, M., & Doroudian, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.952675 · Cited by 105
Reactive Oxygen Species-Activated Nanomaterials as Theranostic Agents
Kim, K. S., Lee, D., Song, C. G., & Kang, P. M. (2015) · Nanomedicine · doi:10.2217/nnm.15.108 · Cited by 98
Non-invasive molecular imaging of kidney diseases
Klinkhammer, B. M., Lammers, T., Mottaghy, F. M., Kiessling, F. M., Floege, J., & Boor, P. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00440-4 · Cited by 99
Nanoparticles for biomedical applications: An overview
Khan, H. A., Sakharkar, M. K., Nayak, A., Kishore, U., & Khan, A. U. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100716-7.00014-3 · Cited by 92
Nanomaterials and their Classification
Buzea, C., & Pacheco, I. (2016) · Advanced structured materials · doi:10.1007/978-81-322-3655-9_1 · Cited by 92
Suciu, M., Ionescu, C. M., Ciorîţă, A., Tripon, S. C., Nica, D. V., Al‐Salami, H., & Barbu–Tudoran, L. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.94 · Cited by 88
Santiesteban, D. Y., Dumani, D. S., Profili, D., & Emelianov, S. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02105 · Cited by 87
Organ Distribution and Bone Tropism of Cellulose Nanocrystals in Living Mice
Colombo, L., Zoia, L., Violatto, M. B., Previdi, S., Talamini, L., Sitia, L., Nicotra, F., Orlandi, M. E., Salmona, M., Recordati, C., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00805 · Cited by 81
Yung, B. C., Li, J., Zhang, M., Cheng, X., Li, H., Yung, E. M., Chen, K., Cosby, L. E., Liu, Y., Teng, L., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00878 · Cited by 83
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium
Atukorale, P. U., Covarrubias, G., Bauer, L., & Karathanasis, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.09.006 · Cited by 82
Giannakou, C., Park, M. V. D. Z., de Jong, W., Loveren, H. V., Vandebriel, R. J., & Geertsma, R. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s102385 · Cited by 79
Mechanisms of nanoparticle radiosensitization
Kempson, I. M. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1656 · Cited by 77
Köse, G., Darguzyte, M., & Kiessling, F. M. (2020) · Nanomaterials · doi:10.3390/nano10101935 · Cited by 75
Gómez‐Vallejo, V., Puigivila, M., Plaza‐García, S., Szczupak, B., Piñol, R., Murillo, J. L., Sorribas, V., Lou, G., Veintemillas-Verdaguer, S., Ramos‐Cabrer, P., et al. (2018) · Nanoscale · doi:10.1039/c8nr03084g · Cited by 75
Nanocarriers for cancer nano-immunotherapy
Rana, I., Oh, J., Baig, J., Moon, J. H., Son, S., & Nam, J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01241-3 · Cited by 76
Wang, G., Inturi, S., Serkova, N. J., Merkulov, S., McCrae, K. R., Russek, S. E., Banda, N. K., & Simberg, D. (2014) · ACS Nano · doi:10.1021/nn505126b · Cited by 71
The theranostic path to personalized nanomedicine
Theek, B., Rizzo, L. Y., Ehling, J., Kiessling, F. M., & Lammers, T. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0051-5 · Cited by 71
Applying nanomedicine in maladaptive inflammation and angiogenesis
Alaarg, A., Pérez‐Medina, C., Metselaar, J. M., Nahrendorf, M., Fayad, Z. A., Storm, G., & Mulder, W. J. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.009 · Cited by 60
Quinone-fused porphyrins as contrast agents for photoacoustic imaging
Banala, S., Fokong, S., Brand, C., Andreou, C., Kräutler, B., Rueping, M., & Kiessling, F. M. (2017) · Chemical Science · doi:10.1039/c7sc01369h · Cited by 58
Nanotechnology-Based Strategies to Develop New Anticancer Therapies
Magro, M., Venerando, A., Macone, A., Canettieri, G., Agostinelli, E., & Vianello, F. (2020) · Biomolecules · doi:10.3390/biom10050735 · Cited by 58
The potential of nanoparticles for the immunization against viral infections
Sokolova, V., Westendorf, A. M., Buer, J., Überla, K., & Epple, M. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00618j · Cited by 57
Shuvaev, S., Akam, E. A., & Caravan, P. D. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000731 · Cited by 56
Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases
Chopra, H., Bibi, S., Mishra, A. K., Tirth, V., Yerramsetty, S. V., Murali, S. V., Ahmad, S. U., Mohanta, Y. K., Attia, M. S., Algahtani, A., et al. (2022) · Journal of Nanomaterials · doi:10.1155/2022/4155729 · Cited by 59
Nanoparticles in Combating Cancer: Opportunities and Limitations: A Brief Review
Pędziwiatr‐Werbicka, E., Horodecka, K., Shcharbin, D., & Bryszewska, M. J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200130101605 · Cited by 54
Arora, H., Ramesh, M., Rajasekhar, K., & Govindaraju, T. (2020) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20190356 · Cited by 53
Oda, C. M. R., Fernandes, R. S., Lopes, S. C. D. A., Oliveira, M. C., Cardoso, V. N., dos Santos, D. M., Pimenta, A. M. C., Malachias, Â., Paniago, R. M., Townsend, D. M., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.144 · Cited by 52
Synthesis, properties, and biomedical applications of inorganic bionanomaterials
Shojaei, T. R., Soltani, S., & Derakhshani, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824147-9.00006-6 · Cited by 49
Advancements in Micro/Nanorobots in Medicine: Design, Actuation, and Transformative Application
Weerarathna, I. N., Kumar, P., Dzoagbe, H. Y., & Kiwanuka, L. (2025) · ACS Omega · doi:10.1021/acsomega.4c09806 · Cited by 52
Allard-Vannier, É., Hervé-Aubert, K., Kaaki, K., Blondy, T., Shebanova, A., Шайтан, К. В., Ignatova, A. A., Saboungi, M., Feofanov, A. V., & Chourpa, I. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.045 · Cited by 46
Interaction of Nanoparticles with Blood Components and Associated Pathophysiological Effects
de la Cruz, G. G., Rodriguez-Fragoso, P., Reyes-Esparza, J. A., Rodríguez‐López, A., Gómez‐Cansino, R., & Rodríguez‐Fragoso, L. (2018) · InTech eBooks · doi:10.5772/intechopen.69386 · Cited by 54
Ghazanfari, A., Marasini, S., Miao, X., Park, J. A., Jung, K., Ahmad, M. Y., Yue, H., Ho, S. L., Liu, S., Jang, Y. J., et al. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.05.033 · Cited by 45
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
Chavda, V. P., Sugandhi, V. V., Pardeshi, C. V., Patil, R., Joshi, M., Patel, B. M., Khadela, A. D., Bezbaruah, R., Bhattacharjee, B., Balar, P. C., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104579 · Cited by 44
Zhang, J., Ring, H. L., Hurley, K. R., Shao, Q., Carlson, C. S., Idiyatullin, D., Manuchehrabadi, N., Hoopes, P. J., Haynes, C. L., Bischof, J. C., et al. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26394 · Cited by 42
Clinical translational barriers against nanoparticle-based imaging agents
Jin, R., Fu, X., Pu, Y., Fu, S., Liang, H., Yang, L., Nie, Y., & Ai, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114587 · Cited by 42
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
Friberg, S. G., & Nyström, A. M. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0172-2 · Cited by 43
Advances in the clinical translation of nanotechnology
Scheinberg, D. A., Grimm, J., Heller, D. A., Stater, E. P., Bradbury, M. S., & McDevitt, M. R. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.01.002 · Cited by 40
Sulheim, E., Kim, J., van Wamel, A. J. E. T., Kim, E., Snipstad, S., Vidić, I., Grimstad, I. H., Widerøe, M., TORP, S. H., Lundgren, S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.026 · Cited by 43
Carrasco, V., Amarelle, V., Lagos-Moraga, S., Quezada, C. P., Espinoza-González, R., Faccio, R., Fabiano, E., & Perez-Donoso, J. M. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01531-4 · Cited by 41
Unni, M., Savliwala, S., Partain, B. D., Maldonado-Camargo, L., Zhang, Q., Narayanan, S., Đufresne, E. M., Ilavský, J., Gryboś, P., Kozioł, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8467 · Cited by 41
Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features
Stendahl, J. C., & Sinusas, A. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160994 · Cited by 38
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
Tuguntaev, R. G., Hussain, A., Fu, C., Chen, H., Tao, Y., Huang, Y. H., Liu, L., Liang, X., & Guo, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01451-4 · Cited by 41
Hobson, N. J., Weng-Jiang, X., Siow, B. M., Veiga, C., Ashford, M. B., Thanh, N. T. K., Schätzlein, A. G., & Uchegbu, I. F. (2019) · Nanomedicine · doi:10.2217/nnm-2018-0370 · Cited by 40
Sun, X., Wang, Y., Wen, S., Huang, K., Huang, J., Chu, X., Wang, F., & Pang, L. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00784-w · Cited by 37
Nanoparticles for MRI-guided radiation therapy: a review
Smith, L., Byrne, H. L., Waddington, D. E. J., & Kuncic, Z. (2022) · Cancer Nanotechnology · doi:10.1186/s12645-022-00145-8 · Cited by 37
Banerjee, A., Błasiak, B., Dash, A., Tomanek, B., van Veggel, F. C. J. M., & Trudel, S. (2022) · Chemical Physics Reviews · doi:10.1063/5.0064517 · Cited by 36
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18
Coenen, H. H., & Ermert, J. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.07.003 · Cited by 35
Carbon dots as multi-modal contrast agents: opportunities and open challenges for in vivo bioimaging
Sturabotti, E., Sierra-Serrano, B., Apresto, S. M., Cesco, M., Comparini, L., Cardo, L. F., & Prato, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115659 · Cited by 39
Pham, T., Lengkeek, N. A., Greguric, I. D., Kim, B., Pellegrini, P. A., Bickley, S. A., Tanudji, M. R., Jones, S. K., Hawkett, B. S., & Pham, B. T. T. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s127171 · Cited by 32
Delivery of Nanoconstructs in Cancer Therapy: Challenges and Therapeutic Opportunities
Saw, W. S., Anasamy, T., Foo, Y. Y., Kwa, Y. C., Kue, C. S., Yeong, C. H., Kiew, L. V., Lee, H. B., & Chung, L. Y. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000206 · Cited by 33
Pathak, V., Nolte, T., Rama, E., Rix, A., Dadfar, S. M., Paefgen, V., Banala, S., Buhl, E. M., Weiler, M., Schulz, V., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120896 · Cited by 33
Lateef, A., Darwesh, O. M., & Matter, I. A. (2021) · Materials horizons · doi:10.1007/978-981-33-4777-9_1 · Cited by 32
Wu, L., Wang, C., & Li, Y. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0246 · Cited by 32
Clinical translation and landscape of superparamagnetic iron oxide nanoparticles
Li, Y., Barmin, R. A., Zhang, R., Kiessling, F. M., Lammers, T., & Pallares, R. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115756 · Cited by 36
Micelle-engineered nanoplatforms for precision oncology
Gao, W., Bigham, A., Ghomi, M., Zarrabi, A., Rabiee, N., Saeb, M. R., Ertaş, Y. N., Goel, A., Sharifi, E., Ashrafizadeh, M., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153438 · Cited by 31
Polymer-based nanoparticles for cancer theranostics: advances, challenges, and future perspectives
Shanahan, K., Coen, D., & Nafo, W. (2025) · Exploration of BioMat-X · doi:10.37349/ebmx.2025.101342 · Cited by 29
Li, S., Yuan, C., Chen, J., Chen, D., Chen, Z., Chen, W., Yan, S., Hu, P., Xue, J., Li, R., et al. (2019) · Theranostics · doi:10.7150/thno.29445 · Cited by 28
Iron Homeostasis-Regulated Adaptive Metabolism of PEGylated Ultrasmall Iron Oxide Nanoparticles
Wang, N., Zhou, D., Xu, K., Kou, D., Chen, C., Li, C., Ge, J., Chen, L., Zeng, J., & Gao, M. (2025) · ACS Nano · doi:10.1021/acsnano.5c01399 · Cited by 29
Vedelago, J., Mattea, F., & Valente, M. (2018) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2018.02.028 · Cited by 27
Nanoheterostructures (NHS) and Their Applications in Nanomedicine: Focusing on In Vivo Studies
Quarta, A., Piccirillo, C., Mandriota, G., & Corato, R. D. (2019) · Materials · doi:10.3390/ma12010139 · Cited by 27
Molkenova, A., Atabaev, T. S., Hong, S. W., Mao, C., Han, D., & Kim, K. S. (2022) · Materials Today Nano · doi:10.1016/j.mtnano.2022.100187 · Cited by 27
89Zr‐ and Fe‐Labeled Polymeric Micelles for Dual Modality PET and T1‐Weighted MR Imaging
Starmans, L. W. E., Hummelink, M. A. P. M., Rossin, R., Kneepkens, E., Lamerichs, R. M. J. N., Donato, K., Nicolay, K., & Grüll, H. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500414 · Cited by 26
Kaittanis, C., Shaffer, T. M., Bolaender, A., Appelbaum, Z., Appelbaum, J., Chiosis, G., & Grimm, J. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03370 · Cited by 26
Porous Nanomaterials Targeting Autophagy in Bone Regeneration
Zhang, Q., Xiao, L., & Xiao, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101572 · Cited by 24
Bridging The Gap Between Lab and Clinic for Nanodiagnostics
Pallares, R. M., Kiessling, F. M., & Lammers, T. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0067 · Cited by 25
Liquid tissue surrogates for X‐ray and CT phantom studies
FitzGerald, P. F., Colborn, R. E., Edic, P. M., Lambert, J. W., Bonitatibus, P. J., & Yeh, B. M. (2017) · Medical Physics · doi:10.1002/mp.12617 · Cited by 25
Metadata
- Authors
- Kiessling, F., Mertens, M. E., Grimm, J., & Lammers, T.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- RWTH Aachen University (DE)
- Venue
- Radiology
- Published
- 2014-10
- Volume
- 273
- Issue
- 1
- Pages
- 10-28
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- PMC
- PMC4186876
- OpenAlex
- W2101873325
- Cited by
- 228
- References
- 157
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 7 · 2023: 16 · 2022: 22 · 2021: 36 · 2020: 27 · 2019: 16 · 2018: 23 · 2017: 26 · 2016: 21 · 2015: 10 · 2014: 3
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Radiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Cancer Institute (P30CA008748)
- National Institute of Biomedical Imaging and Bioengineering (R01EB014944)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- nanoparticles, molecular imaging, theranostics, pharmacokinetics, nanoparticle toxicity, biodegradation, macrophage uptake, enhanced permeability and retention effect, targeted drug delivery, stem cell tracking, tissue-engineered grafts, imaging biomarkers, tissue distribution
- MeSH terms
- Biocompatible Materials, Contrast Media, Diagnostic Imaging, Humans, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review